← Back to Patent Explorer
US5320616A Expired / Lapsed US ⏱️ 0.0 years remaining

Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement

Assignee: Alza Corp
•
Filing: 1991-11-07
•
Granted: 1994-06-14
•
Expires: 2011-11-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the passage of fluid into the system and a composition that permits the passage of fluid into the system. The lumen comprises a beneficial agent and an expandable member. The delivery system comprises an exit means for delivering the beneficial agent.

Inventors

  • 👤 Judy A. Magruder
  • 👤 James B. Eckenhoff
  • 👤 Richard Cortese
  • 👤 Jeremy C. Wright
  • 👤 John R. Peery

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 20:49
CPC Classifications
A; A61; A61M; A61M31/00; A61K; A61K9/00; A61K9/0002; A61K9/0004; A61M31/002

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 235 words
A delivery system for delivering a beneficial agent to a fluid environment of use, wherein the delivery system comprises: (a) two wall sections, said sections comprising: (b) a first wall section comprising a polymer composition that substantially limits the passage of zero to one ml per day of fluid through the first wall section; (c) a second wall section comprising a cellulosic polymer composition pervious to the passage of fluid, which first wall section and second wall section surround; (d) a reservoir formed by the two sections assembled together by at least one process selected from fusion, adhesion and telescopic engagement; (e) 5 nanograms to 40 grams of a fluid sensitive biological beneficial agent in the reservoir and surrounded by the first wall section for protecting the beneficial agent from the fluid; (f) 0.1% to 90% of a pharmaceutically acceptable carrier in the reservoir surrounded by the first wall section and blended with the beneficial agent for transporting the beneficial agent from the reservoir; (g) a composition comprising a fluid absorbing hydrophilic polymer for expanding and pushing the beneficial agent from the first wall section of the reservoir, said composition in the reservoir surrounded by the second wall section pervious to the passage of fluid; and (h) an exit in the first wall section connecting the beneficial agent with the environment of use for delivering the beneficial agent at a hydrodynamically controlled rate over time.
Claim 2
Dependent Claim 235 words
A delivery system for delivering a beneficial agent to a fluid environment of use, wherein the delivery system comprises: (a) two wall sections, said sections comprising: (b) a first wall section comprising a polymer composition that substantially limits the passage of zero to one ml per day of fluid through the first wall section; (c) a second wall section comprising a cellulosic polymer composition pervious to the passage of fluid, which first wall section and second wall section surround; (d) a reservoir formed by the two sections assembled together by at least one process selected from fusion, adhesion and telescopic engagement; (e) 5 nanograms to 40 grams of a fluid sensitive biological beneficial agent in the reservoir and surrounded by the first wall section for protecting the beneficial agent from the fluid; (f) 0.1% to 90% of a pharmaceutically acceptable carrier in the reservoir surrounded by the first wall section and blended with the beneficial agent for transporting the beneficial agent from the reservoir; (g) a composition comprising a fluid absorbing hydrophilic polymer for expanding and pushing the beneficial agent from the first wall section of the reservoir, said composition in the reservoir surrounded by the second wall section pervious to the passage of fluid; and (h) an exit in the first wall section connecting the beneficial agent with the environment of use for delivering the beneficial agent at a hydrodynamically controlled rate over time.
Claim 3
Dependent Claim 61 words
The delivery system for delivering the beneficial agent according to claim 1, wherein the beneficial agent is a member selected from the group consisting of a pharmacologically active peptide, protein, anabolic hormone, growth promoting hormone, endocrine hormone, porcine growth promoting hormone, bovine growth promoting hormone, equine growth promoting hormone, human growth promoting hormone, and growth promoting hormone produced by recombinant DNA.
Claim 4
Dependent Claim 19 words
The delivery system for delivering the beneficial agent according to claim 1, wherein the delivery system is an implant.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-06-13 1997-12-13 1998-06-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-06-13 2001-12-13 2002-06-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-06-13 2005-12-13 2006-06-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag